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Identity 
Alias: Louis-Bar syndrome 
Note: See also, in Deep Insight section: Ataxia-
Telangiectasia and variants. 
Inheritance: Autosomal recessive; frequency is about 
1 to 2.5/105 newborns; heterozygotes are estimated to 
be 1% of the general population; founder effect are 
found in some isolated population. 
Clinics 
Note 
Ataxia telangiectasia is a chromosome instability 
syndrome with cerebellar degeneration, 
immunodeficiency, and an increased risk of cancers; A-
T cells are defective in recognizing double-strand DNA 
damage to signal for repair. 
Phenotype and clinics 
- Onset of the disease is often noted during the second 
year of life: there is progressive cerebellar ataxia 
(initially truncal, with further peripheral extension); 
ataxia is a constant feature in this disease; oculomotor 
apraxia, dysarthria, and dystonia; leading to muscular 
atrophia.  
- Telangiectasia: facial region exposed to sunlight, and 
eyes (conjunctiva).  
- Combined immunodeficiency (in 70%): thymus 
hypoplasia, and IgG2 and 4, IgA, IgE deficiency. 
- Other features: growth retardation; hypogonadism; 
occasionally diabetes mellitus. 
Neoplastic risk 
Risk of cancers is X 100, consisting mainly of T-cell 
malignancies (a 70-fold and 250-fold increased risks of 
leukemia and lymphoma respectively) and B-cell 
malignancies, but not myeloid leukemia; carcinomas of 
the skin, ovary, breast, and stomach have also been 
described. 
Cancer treatment is complicated by radiation- and 
chemo-sensitivity. 
Evolution 
Progressive cerebellar degeneration: patients are 
usually in a wheelchair by the age of ten. 
Prognosis 
Respiratory infection is the common cause of death, 
with cancer being the second most common. 
Survival is often into fourth decade today where 
optimal medical care is available. 
Cytogenetics 
Inborn conditions 
Spontaneous chromatid/chromosome breaks, triradials, 
quadriradials (less prominent phenomenon than in 
Fanconi anaemia); telomeric associations. 
The best diagnosis test is on the (pathognomonic) 
highly elevated level (10% of mitoses) of 
inv(7)(p14q35), t(14;14)(q11;q32), and other non 
clonal stable chromosome rearrangements involving 
2p12, 7p14, 7q35, 14q11, 14q32, and 22q11 
(illegitimate recombinations between immunoglobulin 
superfamilly genes Ig and TCR); normal level of those 
rearrangements are: 1/500 (inv(14)), 1/200 (t(7;14)), 
1/10 000 (inv(7)). 
Clonal rearrangements further occur in 10% of patients, 
but without manifestation of malignancy: t(14;14), 
inv(14), or t(X;14). 
Cytogenetics of cancer 
Clonal rearrangements in T-cell ALL and T-PLL 
(prolymphocytic leukaemia) in AT patients are 
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complex, with the frequent involvement of 
t(14;14)(q11;q32), or t(X;14)(q28;q11), implicating the 
genes TCL1 or MTCP1 respectively, as is found in T-
PLL in non-AT patients. 
Other findings 
Note 
- High sensitivity to ionizing radiations and to 
radiomimetic drugs (diagnostic may in part be based on 
the hypersensitivity of AT lymphocytes to killing by 
gamma irradiation); cell irradiation does not inhibit S 
phase (DNA synthesis): this is quite pathognomonic of 
AT, and shows that G1 checkpoint is deficient; there is 
a lack of P53, GADD45 and P21 induction, and a fall 
in radiation-induced apoptosis; P53 phosphorylation at 
ser15 is deficient. 
- Lenthening of the cell cycle. 
- Difficult to grow cells with phytohemaglutinin: 
karyotypes should be performed with interleukin 2 in 4 
days cultures. 
- Other: increased level of serum alpha-fetoprotein. 





Description: 66 exons spanning 184 kb of genomic 
DNA. 
Protein 
Description: 3056 amino acids; 350 kDa; contains a Pl 
3-kinase-like domain. 
Localisation: Mostly in the nucleus in replicating cells, 
cytoplasm in differentiating cells. 
Function: Mediates cell cycle arrest in response to 
ionizing radiation through the phophorylation of targets 
including p53, cAbl, IkB-alpha and chk1. 
Mutations 
Germinal: Various types of mutations, dispersed 
throughout the gene, and therefore most patients are 
compound heterozygotes; however, most mutations 
appear to inactivate the ATM protein by truncation, 
large deletions, or annulation of initiation or 
termination. 
To be noted 
Note 
Heterozygote cancer risk: the relative risk of breast 
cancer in A-T heterozygote women has been estimated 
through epidemiological studies to be 3.9 (CI 2.1-7.1), 
and through haplotype analysis to be 3.32 (CI 1.75-
6.38); since the A-T heterozygote frequency is about 
1%, 2-4% of breast cancer cases may be due to ATM 
heterozygosity; the risk of other types of cancer in A-T 
heterozygotes is low. 
The A-T variant Nijmegen breakage syndrome does not 
involve the same gene. 
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